American Research & Management Co. Exact Sciences Corp Transaction History
American Research & Management Co.
- $362 Million
- Q3 2022
A detailed history of American Research & Management Co. transactions in Exact Sciences Corp stock. As of the latest transaction made, American Research & Management Co. holds 950 shares of EXAS stock, worth $57,351. This represents 0.01% of its overall portfolio holdings.
Number of Shares
950
Previous 950
-0.0%
Holding current value
$57,351
Previous $37,000
16.22%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding EXAS
# of Institutions
674Shares Held
163MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$1.07 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$956 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$865 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$728 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$403 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10.7B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...